The UnitedHealth Group (NYSE: UNH) board of directors has authorized payment of a cash dividend of $2.10 per share, to be ...

ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced the U.S. Food and Drug Administration (FDA ...

Scoreboard: The operations committee voted to recommend acceptance of a new electronic scoreboard for the varsity baseball ...

Three months after voters approved Proposition 36 to reclassify certain petty theft and drug crimes as felonies, the Los ...

The Iraqi cabinet approved on Tuesday the Ministry of Electricity's $480 million initiative to rehabilitate the Al Dora ...

A settlement has been reached in a lawsuit alleging race discrimination and retaliation, among other complaints, filed by ...

Kentucky Gov. Andy Beshear took action Thursday to fill an unintended shortfall in the state's main funding source for K-12 ...

(RTTNews) - Neurocrine Biosciences, Inc. (NBIX) said its Board has authorized a new share repurchase program under which Neurocrine may repurchase up to $500 million of its shares. The new share ...

The EU Commission has authorised a grant of up to €920 million from the German government to Infineon for the new chip ...

A new 4-week plan by Knox County for hiring dispatchers at the Knox Regional Communications Center is being enacted, and the ...

The U.S. Food and Drug Administration (FDA) has authorized the marketing of Zyn nicotine pouches as a reduced-risk ...